Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$42.1K Buy
911
+6
+0.7% +$275 ﹤0.01% 2480
2026
Q2
$29.6K Sell
905
-47
-5% -$1.69K ﹤0.01% 2620
2026
Q1
$33.7K Sell
952
-415
-30% -$16.9K ﹤0.01% 2438
2025
Q4
$55.5K Sell
1,367
-403
-23% -$17.5K ﹤0.01% 2001
2025
Q3
$83.2K Buy
1,770
+228
+15% +$11.8K ﹤0.01% 1636
2025
Q2
$80.3K Buy
1,542
+225
+17% +$12.3K 0.01% 1603
2025
Q1
$79.5K Buy
1,317
+591
+81% +$38.1K 0.01% 1445
2024
Q4
$49.7K Buy
726
+351
+94% +$24.5K ﹤0.01% 1665
2024
Q3
$27K Buy
375
+117
+45% +$8.26K ﹤0.01% 1925
2024
Q2
$17.9K Buy
258
+172
+200% +$12.5K ﹤0.01% 1924
2024
Q1
$6.89K Sell
86
-283
-77% -$25.2K ﹤0.01% 2255
2023
Q4
$35.3K Buy
+369
New +$38.2K 0.01% 1119

Other funds holding CNMD

GAMMA Investing's CNMD Position: Q3 2026 in Review

GAMMA Investing increased its CONMED (CNMD) stake by 0.66% in Q3 2026, buying an estimated $275 and bringing the position to 911 shares worth $42.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2480.

GAMMA Investing first reported a position in CNMD in Q4 2023 and has held it in 12 quarters since. The position peaked at $83.2K in Q3 2025. 11 funds tracked by Wall St. Rank hold CNMD as of Q3 2026.

  • GAMMA Investing held 911 shares of CONMED worth $42.1K as of Q3 2026.
  • GAMMA Investing bought 6 CONMED shares in Q3 2026, an estimated $275.
  • CONMED made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2480 holding.
  • GAMMA Investing first reported a position in CONMED in Q4 2023 and has held it in 12 quarters since.
  • GAMMA Investing's CONMED position peaked at $83.2K in Q3 2025.
  • 11 funds tracked by Wall St. Rank held CONMED as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.